Avalyn Pharma Inc.

Healthcare · Biotechnology · United States

Last price 25.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.14B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose ...